000 | 01287 a2200361 4500 | ||
---|---|---|---|
005 | 20250511161244.0 | ||
264 | 0 | _c19761121 | |
008 | 197611s 0 0 eng d | ||
022 | _a0021-9150 | ||
024 | 7 |
_a10.1016/0021-9150(76)90148-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRogers, M P | |
245 | 0 | 0 |
_aEffects of clofibrate treatment on plasma triglyceride concentration, plasma post-heparin clearing factor lipase (lipoprotein lipase) activity and serum clearing factor lipase activating ability in maturity-onset diabetes. _h[electronic resource] |
260 |
_bAtherosclerosis _cSep 1976 |
||
300 |
_a565-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBlood Proteins _xphysiology |
650 | 0 | 4 |
_aClofibrate _xtherapeutic use |
650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHeparin |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLipoprotein Lipase _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTriglycerides _xblood |
700 | 1 | _aBarnett, D | |
700 | 1 | _aRobinson, D S | |
773 | 0 |
_tAtherosclerosis _gvol. 24 _gno. 3 _gp. 565-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0021-9150(76)90148-9 _zAvailable from publisher's website |
999 |
_c978882 _d978882 |